Home › Funds › Atom Investors LP › IMVT
Atom Investors LP position in IMVT
IMMUNOVANT INC · Health Care
Atom Investors LP reported holding 176,658 shares of IMVT (IMMUNOVANT INC) in its Q3 2026 13F filing — a position valued at US$6.0M, representing 0.41% of its reported portfolio and ranking #39 among its reported holdings. Atom Investors LP has disclosed IMVT holdings in 3 of the last 12 reported quarters, going back to Q4 2023.
Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR
How Atom Investors LP's IMVT position evolved
Atom Investors LP first disclosed a stake in IMVT in Q4 2023 at 5,431 shares (US$229K). The position peaked in Q3 2026 at 176,658 shares, worth US$6.0M. Across 3 filings, Atom Investors LP increased the stake 1 time(s), trimmed it 0 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 176,658 shares valued at US$6.0M — an increase of 102,487 shares quarter over quarter.. Notable position changes include a 138% increase in Q3 2026 (shares rose 1% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2023 | 5.43K | $228.81K | New |
| Q2 2026 | 74.17K | $2.86M | New |
| Q3 2026 | 176.66K | $5.97M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About IMVT and 13F data
IMVT (IMMUNOVANT INC) is a Health Care company. 38 other funds we track also report a position in IMVT — the largest reported positions include Deep Track Capital, LP (US$309.5M), Farallon Capital Management (US$223.7M), FARALLON CAPITAL MANAGEMENT, L.L.C. (US$218.6M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding IMVT
- Deep Track Capital, LP 9.16M sh · $309.45M · Q3 2026
- Farallon Capital Management 5.80M sh · $223.67M · Q2 2026
- FARALLON CAPITAL MANAGEMENT, L.L.C. 6.47M sh · $218.59M · Q3 2026
- BAKER BROS. ADVISORS LP 5.44M sh · $209.42M · Q2 2026
- Two Seas Capital LP 4.61M sh · $155.82M · Q3 2026
- TCG Crossover Management, LLC 4.46M sh · $150.59M · Q3 2026
- RTW INVESTMENTS, LP 3.18M sh · $107.35M · Q3 2026
- ADAR1 Capital Management, LLC 2.12M sh · $71.46M · Q3 2026
- ARMISTICE CAPITAL, LLC 1.62M sh · $54.89M · Q3 2026
- PERCEPTIVE ADVISORS LLC 1.36M sh · $52.30M · Q2 2026
- Alpine Global Management, LLC 1.37M sh · $46.26M · Q3 2026
- SILVERARC CAPITAL MANAGEMENT, LLC 624.05K sh · $21.08M · Q3 2026
More on Atom Investors LP
FAQ
How long has Atom Investors LP held IMVT?
Atom Investors LP has disclosed IMVT holdings in 3 of the last 12 reported quarters, going back to Q4 2023.
What is Atom Investors LP's current position in IMVT?
As of Q3 2026, Atom Investors LP holds 176.66K shares of IMVT (IMMUNOVANT INC), valued at $5.97M, representing 0.41% of its reported portfolio and ranking #39.
Has Atom Investors LP been buying or selling IMVT?
In the latest 13F filing (Q3 2026), Atom Investors LP increased its position in IMVT. The position peaked in Q3 2026 at 176.66K shares.
Which other funds hold IMVT?
Other major institutional holders of IMVT include Deep Track Capital, LP, Farallon Capital Management, FARALLON CAPITAL MANAGEMENT, L.L.C., among 38 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.